PEPTIDE CORPUS

Cognitive & Neuroprotection

PEA

An oral fatty-acid amide for pain and inflammatory tone research.

Last updated

Studied forChronic pain support · Neuropathic pain support · Gut-barrier modulation
Evidence on file4 randomised human trials · 1 human observational study · 1 citation not yet graded
Strongest sourceRandomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and… (randomised human trial)

Mechanism

Influences PPAR-alpha activation, mast-cell ALIA signaling, and TRPV1 modulation.

Reported effects

What sources associate with this compound. Reported categories, not outcomes we have graded — each would need its own citation and rung.

  • Chronic pain support
  • Neuropathic pain support
  • Gut-barrier modulation

Dosing on file unverified

300-600 mg BID, cycled 8–12 weeks

Carried from a source that labels it unverified, and reproduced with that label attached. A record of what is reported, not a recommendation. No citation on this page establishes it.

Literature on file 6

Not graded

1 citation whose study design could not be read from the title. Left ungraded rather than guessed at.

Identity

Also called

  • PEA

Not on file 8

8 of the 8 fields we track hold nothing on this record, and each says why. A blank field is a bug; a named absence is a finding.

Each field links to every other record missing the same thing. The full ledger holds 521 gaps across 136 records.

Listed prices 1

What 1 shop we track listed for PEA, read from their own public catalogues on 2026-08-12. We take no commission on these and they are not ranked by any payment — how vendors are scored.

Currency not stated by the vendor — these are not compared with any priced row
VendorSizePricePer mg
Healthgevity size not listed 94.99 (currency not stated)

Prices are the vendor's own listing, reproduced with the date we read it — never converted between currencies, and compared per milligram only where the vendor states the vial size.